HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy

Introduction: Loss of HBsAg is observed in only 3-4% of patients who receive interferon for chronic HBV+HCV hepatitis, and there are few reports of HBsAg loss induced by treatments other than interferon. We report a case of chronic HBV+HCV hepatitis, in which a positive outcome was achieved with a n...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Antonio Salvio, Maria Varriale, Tito d’Errico, Gennaro De Siena, Mario Visconti
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	PAGEPress Publications 2012-01-01
Rangatū:	Italian Journal of Medicine
Ngā marau:	Chronic hepatitis Coinfection Hepatitis B Virus (HBV) Hepatitis C Virus (HCV) Peginterferon-alfa Ribavirin.
Urunga tuihono:	http://www.italjmed.org/index.php/ijm/article/view/116
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!